- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 279/16 - 1,4-ThiazinesHydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Patent holdings for IPC class C07D 279/16
Total number of patents in this class: 117
10-year publication summary
|
9
|
7
|
8
|
7
|
7
|
7
|
1
|
8
|
5
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Elkimia, Inc. | 8 |
6 |
| VALO Health, Inc. | 175 |
5 |
| The Regents of the University of Michigan | 4751 |
4 |
| Icahn School of Medicine at Mount Sinai | 962 |
4 |
| Japan Tobacco Inc. | 3600 |
4 |
| Vertex Pharmaceuticals Incorporated | 1626 |
3 |
| Curadev Pharma Pvt Ltd. | 21 |
3 |
| KYORIN Pharmaceutical Co., Ltd. | 167 |
3 |
| Purdue Pharma L.P. | 502 |
3 |
| Suven Life Sciences Limited | 135 |
3 |
| Mangosuthu University of Technology | 4 |
3 |
| Bristol-myers Squibb Company | 4849 |
2 |
| Genentech, Inc. | 4009 |
2 |
| The Board of Trustees of the University of Illinois | 2719 |
2 |
| Astellas Pharma Inc. | 1087 |
2 |
| Elkimia | 2 |
2 |
| Galderma Research & Development | 398 |
2 |
| Georgia State University Research Foundation, Inc. | 348 |
2 |
| The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | 117 |
2 |
| Lycera Corporation | 31 |
2 |
| Other owners | 58 |